NCT00081107View on ClinicalTrials.gov

Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 2003

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions

Lung Cancer

Interventions

DRUG

epothilone D

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00081107 - Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy | Biotech Hunter | Biotech Hunter